H-Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His Leu Asn Ser Met Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His Asn Phe Val Ala Leu Gly Ala Pro Leu Ala Pro Arg Asp Ala Gly Ser Gln Arg Pro Arg Lys Lys Glu Asp Asn Val Leu Val Glu Ser His Glu Lys Ser Leu Gly Glu Ala Asp Lys Ala Asp Val Asn Val Leu Thr Lys Ala Lys Ser Gln-OH
Type
Peptide
Class
Hormonal agent DG01661 Parathyroid hormone and analog
peptide hormone
Treatment of osteoporosis, as an antiosteoporotic, in the treatment of bone and mineral disease and disorders, bone metabolism regulator, blood calcium regulator
Endocrine and other factor-regulated calcium reabsorption
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05 CALCIUM HOMEOSTASIS
H05A PARATHYROID HORMONES AND ANALOGUES
H05AA Parathyroid hormones and analogues
H05AA03 Parathyroid hormone
D05364 Parathyroid hormone (human) (USAN) <US>
USP drug classification [BR:br08302]
Metabolic Bone Disease Agents
Calcium Regulating Hormones
Parathyroid Hormone
D05364 Parathyroid hormone (human) (USAN)
Drug groups [BR:br08330]
Hormonal agent
DG01661 Parathyroid hormone and analog
D05364 Parathyroid hormone (human)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Parathyroid hormone
PTH1R
D05364 Parathyroid hormone (human) (USAN) <US>
PTH2R
D05364 Parathyroid hormone (human) (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D05364
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D05364
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05364
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D05364
